May 2012 FDA Recall Drug by Bayer Healthcare Pharmaceuticals Inc.
D-156-2013 - Impurities/Degradation Products

This Class III drug recall was voluntarily initiated by Bayer Healthcare Pharmaceuticals Inc. on May 31, 2012 for the product Drug. The FDA reported the reason for recall as impurities/degradation products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-156-2013

Reason for Recall
Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.
Initiated
05-31-2012
Reported
02-13-2013
Quantity
138,505 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Bayer HealthCare Pharmaceuticals Inc.
Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Batch or Lot Expiration Information

Lot# B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12